Fujian Wanchen Biotechnology's Attributable Profit More Than Doubles in H1

MT Newswires Live

Yesterday

Fujian Wanchen Biotechnology's (SHE:300972) attributable profit jumped 157%, or 2.6 times, to 1.21 billion yuan in the first half from 471.6 million yuan in the year-ago period, according to a Saturday filing with the Shanghai/Shenzhen Stock Exchange.

Earnings per share at the edible fungi processor increased to 6.0860 yuan from 2.4184 yuan in the prior-year period.

Operating revenue grew 54% year over year to 34.8 billion yuan from 22.6 billion yuan.

Directors declared a dividend of 1.50 yuan per 10 shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/2663071731"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2663071731\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2663071731?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-31 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2663071731","market":"us","top_or_hot":-1,"title":"Fujian Wanchen Biotechnology's Attributable Profit More Than Doubles in H1","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/300972\">Fujian Wanchen Biotechnology</a>'s (SHE:300972) attributable profit jumped 157%, or 2.6 times, to 1.21 billion yuan in the first half from 471.6 million yuan in the year-ago period, according to a Saturday filing with the Shanghai/Shenzhen Stock Exchange.</p><p>Earnings per share at the edible fungi processor increased to 6.0860 yuan from 2.4184 yuan in the prior-year period.</p><p>Operating revenue grew 54% year over year to 34.8 billion yuan from 22.6 billion yuan.</p><p>Directors declared a dividend of 1.50 yuan per 10 shares.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fujian Wanchen Biotechnology's Attributable Profit More Than Doubles in H1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFujian Wanchen Biotechnology's Attributable Profit More Than Doubles in H1\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-31 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/300972\">Fujian Wanchen Biotechnology</a>'s (SHE:300972) attributable profit jumped 157%, or 2.6 times, to 1.21 billion yuan in the first half from 471.6 million yuan in the year-ago period, according to a Saturday filing with the Shanghai/Shenzhen Stock Exchange.</p><p>Earnings per share at the edible fungi processor increased to 6.0860 yuan from 2.4184 yuan in the prior-year period.</p><p>Operating revenue grew 54% year over year to 34.8 billion yuan from 22.6 billion yuan.</p><p>Directors declared a dividend of 1.50 yuan per 10 shares.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300972","symbol_name":"万辰集团","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2663071731","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2663071731","pubTimestamp":1788170741,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Fujian Wanchen Biotechnology's  attributable profit jumped 157%, or 2.6 times, to 1.21 billion yuan in the first half from 471.6 million yuan in the year-ago period, according to a Saturday filing with the Shanghai/Shenzhen Stock Exchange.Earnings per share at the edible fungi processor increased to 6.0860 yuan from 2.4184 yuan in the prior-year period.Operating revenue grew 54% year over year to 34.8 billion yuan from 22.6 billion yuan.Directors declared a dividend of 1.50 yuan per 10 shares.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300972":"万辰集团","BK0227":"农业","FCA":"First Trust China AlphaDEX Fund"},"translate_title":"福建万辰生物科技上半年应占利润翻了一番多","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300972":0.9,"FCA":0.9},"content_text":"Fujian Wanchen Biotechnology's (SHE:300972) attributable profit jumped 157%, or 2.6 times, to 1.21 billion yuan in the first half from 471.6 million yuan in the year-ago period, according to a Saturday filing with the Shanghai/Shenzhen Stock Exchange.Earnings per share at the edible fungi processor increased to 6.0860 yuan from 2.4184 yuan in the prior-year period.Operating revenue grew 54% year over year to 34.8 billion yuan from 22.6 billion yuan.Directors declared a dividend of 1.50 yuan per 10 shares.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}